News
ABVC
0.6125
-8.05%
-0.0536
Abvc Biopharma Inc: [Amend]General form for registration of securities under the Securities Act of 1933
Press release · 5d ago
Abvc Biopharma Inc: Other preliminary proxy statements
Press release · 6d ago
Abvc Biopharma Inc: Current report
Press release · 05/26 22:31
BRIEF-ABVC Biopharma Receives Deficiency Letter From Nasdaq Listing Qualifications Department
Reuters · 05/26 20:49
Abvc Biopharma Inc: Prospectus [Rule 424(b)(3)]
Press release · 05/22 17:05
Abvc Biopharma Inc: Prospectus [Rule 424(b)(4)]
Press release · 05/22 17:05
ABVC BioPharma Vitargus Phase II Study Received Ethical Approval At Sydney Eye Hospital In Australia
Benzinga · 05/22 12:31
Abvc Biopharma Inc: Quarterly report
Press release · 05/15 16:06
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 05/12 13:06
BRIEF-Abvc Biopharma Receives US Certificate Of PDC-1421 For The Treatment Of Major Depressive Disorder
Reuters · 05/04 12:39
ABVC BioPharma Receives U.S. Patent Certificate Of PDC-1421 For The Treatment Of Major Depressive Disorder
Benzinga · 05/04 12:34
ABVC BioPharma Provides ABV-1601 Update On Phase I Site Initiation Visit Conducted At Cedars-Sinai Medical Center
Benzinga · 04/10 12:31
ABVC BioPharma Provides Vitargus Update On Phase II Site Initiation Visit Conducted At Ramathibodi Hospital In Thailand
Benzinga · 04/06 12:35
ABVC BioPharma GAAP EPS of -$0.52, revenue of $0.97M
Seeking Alpha · 04/03 05:34
BRIEF-ABVC BioPharma Provides Vitargus Update On Phase II Site Initiation Visit Conducted At Srinagarind Hospital In Thailand
Reuters · 03/20 11:13
ABVC Biopharma Says Taiwan Health Ministry Approves Dietary Supplement Tablets
ABVC Biopharma Says Taiwan Health Ministry Approves Dietary Supplement Tablets
MT Newswires · 03/14 10:31
ABVC BioPharma Provides 2023 Pipeline Update
Benzinga · 02/28 13:41
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 02/23 21:31
ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented At 2023 APSARD Conference
Benzinga · 01/19 13:42
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 01/06 18:16
More
Webull provides a variety of real-time ABVC stock news. You can receive the latest news about Abvc Biopharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About ABVC
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on the development of drugs and medical devices derived from plants. The Company develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. It has a pipeline of six drugs and one medical device under development. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1701, ABV-1519, ABV-1703 and ABV-1703. ABV-1504 is a botanical reuptake inhibitor that targets norepinephrine to treat major depressive disorder (MDD). It is developing ABV-1505 for treating attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1701 is a vitreous substitute for vitrectomy. Its ABV-1702 is used to treat myelodysplastic syndrome (MDS). ABV-1703 is a drug for advanced, inoperable, or metastatic pancreatic cancer. Its ABV-1519 is used for the treatment of non-small cell lung cancer.